Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers.

ABSTRACT:

Background

Chemoprevention with anti-estrogens, such as tamoxifen, raloxifene or aromatase inhibitors, have been shown to reduce breast cancer risk in randomized controlled trials; however, uptake among women at high-risk for developing breast cancer remains low. The aim of this study is to identify provider-related barriers to shared decision-making (SDM) for chemoprevention in the primary care setting.

Methods

Primary care providers (PCPs) and high-risk women eligible for chemoprevention were enrolled in a pilot study and a randomized clinical trial of web-based decision support tools to increase chemoprevention uptake. PCPs included internists, family practitioners, and gynecologists, whereas patients were high-risk women, age 35-75 years, who had a 5-year invasive breast

SUBMITTER: Jones T 

PROVIDER: S-EPMC9354269 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature